Platelet transfusion threshold in patients with upper gastrointestinal bleeding: A systematic review

Journal of Clinical Gastroenterology

Volumn 46, Issue 6, 2012, Pages 482-486

  Razzaghi, Anoush ^a   Barkun, Alan N ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

platelet transfusion; platelets; thrombocytopenia; upper gastroenterologic bleeding

Indexed keywords

ARTICLE; EMBASE; HUMAN; MEDLINE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UPPER GASTROINTESTINAL BLEEDING;

GASTROINTESTINAL HEMORRHAGE; HUMANS; PLATELET TRANSFUSION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOCYTOPENIA;

EID: 84862287225     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31823d33e3     Document Type: Article

References (30)

1. Leerdam ME, Vreeburg EM, Rauws EAJ, et al. Acute upper GI bleeding: Did anything change[quest]. Am J Gastroenterol. 2003;98:1494-1499.
2. Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med. 1962;266:905-909.
3. Consensus conference. Platelet transfusion therapy. JAMA. 1987;257:1777-1780.
4. Gmur J, Burger J, Schanz U, et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet. 1991;338:1223-1226.
5. Fanning J, Hilgers RD, Murray KP, et al. Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers. Gynecol Oncol. 1995;59:191-193.
6. GilFernandez JJ, Alegre A, FernandezVillalta MJ, et al. Clinical results of a stringent policy on prophylactic platelet transfusion: Non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant. 1996;18:931-935.
7. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med. 1997;337:1870-1875.
8. Heckman KD, Weiner GJ, Davis CS, et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol. 1997;15:1143-1149.
9. Wandt H, Frank M, Ehninger G, et al. Safety and cost effectiveness of a 10-109/L trigger for prophylactic platelet transfusions compared with the traditional 20-109/L trigger: A prospective comparative trial in 105 patients with acute myeloid leukemia. Blood. 1998;91:3601-3606.
10. Navarro J, Hernandez J, Ribera J, et al. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Haematologica. 1998;83:998-1000.
11. Lawrence JB, Yomtovian RA, Hammons T, et al. Lowering the prophylactic platelet transfusion threshold: A prospective analysis. Leuk Lymphoma. 2001;41:67-76.
12. Zumberg MS, del Rosario MLU, Nejame CF, et al. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Biol Blood Marrow Transplant. 2002;8:569-576.
13. Diedrich B, Remberger M, Shanwell A, et al. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10-109 per L versus 30-109 per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion. 2005;45:1064-1072.
14. Wandt H, Schaefer-Eckart K, Frank M, et al. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2006;37:387-392.
15. Contreras M. Final statement from the consensus conference on platelet transfusion. Transfusion. 1998;38:796-797.
16. Slichter SJ. Evidence-based platelet transfusion guidelines. Hematology. 2007;2007:172-178.
17. British Committee for Standards in Haematology Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122:10-23.
18. Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: Clinical practice guidelines of the american society of clinical oncology. J Clin Oncol. 2001;19:1519-1538.
19. British Committee for Standards in Haematology. Guidelines on the management of massive blood loss. Br J Haematol. 2006;135:634-641.
20. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:207-214.
21. Heddle Nancy M, Cook Richard J, Webert Kathryn E, et al; in collaboration with the Biomedical Excellence for Safer Transfusion Working Party of the International Society for Blood Transfusion Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion. 2003;43: 742-752.
22. Heddle NM, Arnold DM, Webert KE. Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion. 2011;51:430-434.
23. Corash L. How much do we know about the platelet transfusion threshold? Transfusion. 2003;43:691-693.
24. Samama C, Djoudi R, Lecompte T, et al. Perioperative platelet transfusion: Recommendations of the Agence franc'aise De sécurité sanitaire des produits De santé (AFSSaPS) 2003. Can J Anesth. 2005;52:30-37.
25. Cooper ES, Bracey AW, Horvath AE, et al. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets, development Task Force of the College of American Pathologists. JAMA. 1994;271:777-781.
26. Goodnough LT, Johnston MFM, Ramsey G, et al. Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 1990;50:675-683.
27. Stroncek DF, Rebulla P. Platelet transfusions. Lancet. 2007; 370:427-438.
28. Lill M, Snider C, Calhoun L, et al. Analysis of utilization and cost of platelet transfusions in refractory hematology/oncology patients. Transfusion. 1997;37:26S.
29. Meehan KR, Matias CO, Rathore SS, et al. Platelet transfusions: Utilization and associated costs in a tertiary care hospital. Am J Hematol. 2000;64:251-256.
30. Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Andoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting. Am J Gastroenterol. 2004;99:1238-1246.